Page last updated: 2024-09-04

ivabradine and Arteriosclerosis, Coronary

ivabradine has been researched along with Arteriosclerosis, Coronary in 82 studies

Research

Studies (82)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	10 (12.20)	29.6817
2010's	69 (84.15)	24.3611
2020's	3 (3.66)	2.80

Authors

Authors	Studies
Chen, C	1
Chen, T; Fang, X; Huang, J; Xu, X; Zhao, Q; Zheng, J; Zhu, H	2
Tolunay, H	1
Bekele, T; Hailu, A; Mengesha, HG; Otieno, MG; Petrucka, P; Weldearegawi, B	1
Brader, P; Kapl, M; Muster, V; Rainer, P; Reittner, P; Schmidt, A; Szolar, DH; Tillich, M; von Lewinski, D; von Lewinski, F; Wallner, M	1
Wu, A	1
Böhm, M; Custodis, F; Fries, P; Hohneck, AL; Laufs, U; Schirmer, SH; Schneider, G; Ströder, J; Wagenpfeil, S	1
Bangalore, S; Messerli, FH; Tanna, MS	1
Gluud, C; Jakobsen, JC; Maagaard, M; Nielsen, EE	1
Kallistratos, MS; Katsi, V; Makris, T; Manolis, AJ; Skalis, G; Tousoulis, D; Tsioufis, K	1
Böhm, M; Borer, JS; Ferrari, R; Ford, I; Fox, K; Komajda, M; Robertson, M; Steg, PG; Swedberg, K; Tavazzi, L; Tendera, M	1
Jacobshagen, C	1
Bevilacqua, S; Chiti, E; Gensini, GF; Lo Sapio, P; Paperetti, L; Pratesi, C; Romano, SM	1
Egstrup, K; Lambrechtsen, J	1
Aksu, HU; Aktürk, IF; Atasoy, I; Atasoy, MM; Celik, O; Diker, M; Ertürk, M; Yalçın, AA	1
Deedwania, P	1
Ferrari, R; Ford, I; Fox, K; Steg, PG; Tardif, JC; Tendera, M	3
Gloekler, S; Khattab, A; Schild, D; Seiler, C; Steck, H; Stoller, M; Traupe, T; Vogel, R	1
van der Hoeven, NW; van Royen, N	1
Baumann, G; Gericke, C; Hättasch, R; Jochmann, N; Knebel, F; Schröter, F; Stangl, K; Stangl, V	1
Fichtlscherer, S; Fischer-Rasokat, U; Hamm, C; Honold, J; Leick, J; Liebetrau, C; Lochmann, D; Möllmann, H; Spyridopoulos, I	1
Biscaglia, S; Valgimigli, M	1
Otto, CM	1
Caldarola, P; Carbonara, S; Cecere, A; Ciccone, MM; Cortese, F; Gesualdo, M; Iacoviello, M; Lagioia, R; Moncelli, M; Ricci, G; Riccioni, G; Scicchitano, P; Scrutinio, D; Zito, A	1
Alexander, KP; Ohman, EM	1
Asrar Ul Haq, M; Mutha, V; Rudd, N; Subiakto, I; Van Gaal, WJ	1
Caretta, G; Fragasso, G; Pirelli, S	1
Bongo, AS; Cavallino, C; Lupi, A; Rognoni, A; Rosso, R; Secco, GG	1
Angelini, L; Battistoni, I; Perna, GP	1
Bohm, M; Reil, JC	1
Astarita, C; Capuano, N; Cirillo, T; Coppola, A; Rigo, F; Romano, C; Tagliamonte, E	1
Allée, G; Dillinger, JG; Henry, P; Levy, BI; Logeart, D; Maher, V; Manzo Silberman, S; Vitale, C	1
Agricola, E; Camici, PG; Maranta, F; Margonato, A; Rimoldi, O; Tondi, L	1
Fichtlscherer, S; Fischer-Rasokat, U; Hamm, CW; Honold, J; Liebetrau, C; Lochmann, D; Möllmann, H; Spyridopoulos, I; Wolter, S	1
Chassany, O; Ferrari, R; Ford, I; Fox, K; Steg, PG; Tardif, JC; Tendera, M	1
Abbas, A; Muñoz, OC; Porres-Aguilar, M	1
Hu, D; Sun, Y; Yu, J	1
Cammarano, C; Comee, M; Donovan, JL; Malloy, MJ; Silva, M	1
Nguyen, E; Weeda, ER; White, CM	1
Grammatikou, V; Kallistratos, M; Katsivas, A; Zarifis, J	1
Abdel-Salam, Z; Nammas, W	1
Heusch, G; Kleinbongard, P	1
Cerny, D; Gloekler, S; Laurent, S; Messerli, FH; Rimoldi, SF; Seiler, C; Traupe, T	1
Camici, PG; Gloekler, S; Heusch, G; Levy, BI; Skalidis, E; Tagliamonte, E; Vardas, P	1
Bangalore, S; Messerli, FH; Rimoldi, SF	1
Balducci, F; Colaiori, I; Creta, A; Demartini, C; Di Sciascio, G; Mangiacapra, F; Minotti, G; Ricottini, E	1
Lopatin, YM; Vitale, C	1
Colombo, A; Godino, C; Margonato, A	1
Böhm, M; Borer, JS; Deedwania, PC; Kim, JB	1
Ferrari, R; Ford, I; Fox, K; Steg, PG; Tendera, M	2
D'Orazio, N; Riccioni, G; Vitulano, N	1
Agewall, S; Atar, D	1
Ferrari, R; Ford, I; Fox, K; Robertson, M; Steg, PG; Tendera, M	1
Heusch, G	2
Akdemir, R; Balci, M; Dogan, M; Kara, E; Murat, SN; Orcan, S	1
Bruguera Cortada, J; Varela, A	1
Riccioni, G	3
Rosano, GM; Vitale, C; Volterrani, M	1
Battler, A; Dvir, D	1
Thollon, C; Vilaine, JP	1
Brunetti, ND; Cademartiri, F; Di Biase, L; Di Biase, M; Guaricci, AI; Ieva, R; Macarini, L; Maffei, E; Midiri, M; Montrone, D; Schuijf, JD; Tedeschi, C	1
Chlouverakis, G; Hamilos, MI; Skalidis, EI; Vardas, PE; Zacharis, EA	1
Ferrari, R; Ford, I; Fox, K; Robertson, M; Steg, PG; Talajic, M; Tardif, JC; Tendera, M	1
Canet, E; Lerebours, G; Vilaine, JP	1
Ferrari, R; Fox, KM	1
Köster, R; Meinertz, T	1
Dock, W; Mendel, H; Pichler, P; Pichler-Cetin, E; Sochor, H; Syeda, B; Vertesich, M	1
Henderson, RA; Timmis, AD	1
Athanasiadis, A; Sechtem, U	1
Adile, KK; Garg, N; Goel, PK; Gupta, A; Jain, SK; Kapoor, A; Kumar, S; Tewari, S	1
Brunetti, ND; Cademartiri, F; Di Biase, L; Di Biase, M; Gentile, G; Guaricci, AI; Macarini, L; Maffei, E; Midiri, M; Montrone, D; Tedeschi, C	1
Büter, I; Gams, E; Hohlfeld, T; Schipke, JD; Schmitz-Spanke, S	1
Barbuti, A; Baruscotti, M; Bucchi, A; DiFrancesco, D	1

Reviews

35 review(s) available for ivabradine and Arteriosclerosis, Coronary

Article	Year
Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials. Clinical therapeutics, 2019, Volume: 41, Issue:10 Topics: Angina Pectoris; Cardiovascular Agents; Coronary Artery Disease; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome	2019
Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials. BMC cardiovascular disorders, 2017, 04-28, Volume: 17, Issue:1 Topics: Aged; Angina, Stable; Benzazepines; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Disease Progression; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome	2017
Heart Failure. Annals of internal medicine, 2018, 06-05, Volume: 168, Issue:11 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors	2018
Stable coronary artery disease: are there therapeutic benefits of heart rate lowering? Journal of hypertension, 2019, Volume: 37, Issue:6 Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Coronary Artery Disease; Heart; Heart Rate; Humans; Ivabradine	2019
Ivabradine and metoprolol in fixed dose combination: When, why and how to use it. Pharmacological research, 2019, Volume: 146 Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; Coronary Artery Disease; Drug Combinations; Heart Rate; Humans; Ivabradine; Metoprolol	2019
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials. European heart journal, 2013, Volume: 34, Issue:29 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiotonic Agents; Coronary Artery Disease; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Treatment Outcome; Ventricular Dysfunction, Left	2013
[Late sodium current and calcium overload--pathogenesis and adequate treatment]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:16 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Atrial Fibrillation; Benzazepines; Calcium; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Electrocardiography; Endothelium, Vascular; Heart Failure, Diastolic; Humans; Hypercalcemia; Ivabradine; Myocardial Ischemia; Nitrates; Piperazines; Ranolazine; Sodium; Sodium Channels; Sodium-Calcium Exchanger	2013
Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure. Drugs, 2013, Volume: 73, Issue:14 Topics: Animals; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Heart Failure; Heart Rate; Humans; Ivabradine	2013
Stable angina pectoris. Current atherosclerosis reports, 2014, Volume: 16, Issue:7 Topics: Acetanilides; Angina, Stable; Benzazepines; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vasospasm; Echocardiography, Stress; Exercise Test; Humans; Ivabradine; Microvessels; Nicorandil; Nitrates; Percutaneous Coronary Intervention; Piperazines; Ranolazine; Smoking Cessation; Vasodilator Agents	2014
Ivabradine, coronary artery disease, and heart failure: beyond rhythm control. Drug design, development and therapy, 2014, Volume: 8 Topics: Animals; Benzazepines; Coronary Artery Disease; Heart Failure; Heart Rate; Humans; Ivabradine	2014
Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy. Cardiovascular & hematological agents in medicinal chemistry, 2015, Volume: 13, Issue:1 Topics: Animals; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Coronary Vessels; Heart Rate; Humans; Ivabradine	2015
[Heart rate modulation in stable ischemic heart disease: what we have learned from the SIGNIFY study?]. Giornale italiano di cardiologia (2006), 2015, Volume: 16, Issue:3 Topics: Benzazepines; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Artery Disease; Drug Interactions; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Risk Factors; Treatment Outcome	2015
Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure. Current cardiology reports, 2016, Volume: 18, Issue:2 Topics: Angina, Stable; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Heart Rate; Humans; Ivabradine; Risk Factors; Treatment Outcome	2016
Meta-analysis of Ivabradine in Patients With Stable Coronary Artery Disease With and Without Left Ventricular Dysfunction. Clinical therapeutics, 2016, Volume: 38, Issue:2 Topics: Adrenergic beta-Antagonists; Benzazepines; Coronary Artery Disease; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left	2016
Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:6 Topics: Angina Pectoris; Benzazepines; Canada; Cardiovascular Diseases; Coronary Artery Disease; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Myocardial Infarction; Stroke Volume; Treatment Outcome	2016
Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction. Drugs, 2016, Volume: 76, Issue:7 Topics: Angina, Stable; Animals; Benzazepines; Cardiotonic Agents; Coronary Artery Disease; Heart Failure; Heart Rate; Humans; Ivabradine; Longevity; Mice; Myocardial Ischemia; Myocardial Reperfusion; Swine	2016
Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction. International journal of cardiology, 2016, Jul-15, Volume: 215 Topics: Adrenergic beta-Antagonists; Angina, Stable; Animals; Benzazepines; Coronary Artery Disease; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic; Sinoatrial Node	2016
Effect of ivabradine on central aortic blood pressure in patients with stable coronary artery disease: What do we know? International journal of cardiology, 2016, Dec-01, Volume: 224 Topics: Arterial Pressure; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Humans; Ivabradine; Treatment Outcome	2016
Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention. Clinical drug investigation, 2017, Volume: 37, Issue:2 Topics: Benzazepines; Cardiotonic Agents; Coronary Artery Disease; Humans; Ivabradine; Percutaneous Coronary Intervention	2017
Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease. The American journal of cardiology, 2016, Dec-15, Volume: 118, Issue:12 Topics: Benzazepines; Cardiovascular Agents; Chronic Disease; Coronary Artery Disease; Heart Failure, Systolic; Heart Rate; Hospitalization; Humans; Ivabradine; Mortality; Quality of Life; Treatment Outcome; Ventricular Function, Left	2016
Ivabradine: beyond heart rate control. Advances in therapy, 2009, Volume: 26, Issue:1 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Heart Failure; Heart Rate; Heart Transplantation; Humans; Ivabradine; Nitrates; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left	2009
Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2009, Volume: 9 Suppl 1 Topics: Aged; Benzazepines; Cardiovascular Diseases; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left	2009
Ivabradine: from molecular basis to clinical effectiveness. Advances in therapy, 2010, Volume: 27, Issue:3 Topics: Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Diabetes Complications; Heart Rate; Humans; Ivabradine; Sinoatrial Node; Ventricular Remodeling	2010
Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction. Advances in therapy, 2010, Volume: 27, Issue:4 Topics: Adrenergic beta-Antagonists; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Randomized Controlled Trials as Topic	2010
Conventional and novel drug therapeutics to relief myocardial ischemia. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Cardiovascular System; Coronary Artery Disease; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Nicorandil; Nitrates; Piperazines; Ranolazine	2010
I(f) inhibition in cardiovascular diseases. Advances in pharmacology (San Diego, Calif.), 2010, Volume: 59 Topics: Adrenergic beta-Antagonists; Animals; Benzazepines; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Artery Disease; Cyclic Nucleotide-Gated Cation Channels; Dogs; Drugs, Investigational; Guinea Pigs; Heart Failure; Heart Rate; Humans; Ivabradine; Mice; Models, Animal; Rabbits; Sinoatrial Node	2010
Heart rate and heart failure. Not a simple relationship. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:2 Topics: Animals; Benzazepines; Cardiac Pacing, Artificial; Coronary Artery Disease; Disease Models, Animal; Heart Failure; Heart Rate; Humans; Ivabradine; Models, Cardiovascular; Multicenter Studies as Topic; Myocardial Ischemia; Myocardium; Randomized Controlled Trials as Topic; Stress, Mechanical; Tachycardia; Tachycardia, Supraventricular; Treatment Outcome; Ventricular Dysfunction, Left; Vertebrates	2011
Ivabradine: recent and potential applications in clinical practice. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:3 Topics: Angina Pectoris; Animals; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Risk Factors; Ventricular Dysfunction, Left	2011
Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine. Annals of the New York Academy of Sciences, 2011, Volume: 1222 Topics: Animals; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Heart Failure; Heart Rate; Humans; Ivabradine; Models, Biological; Risk Assessment; Therapies, Investigational	2011
Heart rate: a forgotten link in coronary artery disease? Nature reviews. Cardiology, 2011, Apr-26, Volume: 8, Issue:7 Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Arteriosclerosis; Benzazepines; Coronary Artery Disease; Coronary Vessels; Disease Progression; Elasticity; Endothelium, Vascular; Heart Rate; Hemodynamics; Humans; Ivabradine; Myocardial Ischemia; Myocardium; Oxygen Consumption	2011
[New agents for the therapy of angina pectoris]. Der Internist, 2011, Volume: 52, Issue:7 Topics: Acetanilides; Angina Pectoris; Benzazepines; Coronary Artery Disease; Cyclic Nucleotide-Gated Cation Channels; Double-Blind Method; Drug Approval; Enzyme Inhibitors; Humans; Ivabradine; Nicorandil; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Vasodilator Agents	2011
[Almanac 2011: Stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology]. Giornale italiano di cardiologia (2006), 2012, Volume: 13, Issue:4 Topics: Acetanilides; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Benzazepines; Biomarkers; Cardiology; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Enzyme Inhibitors; Evidence-Based Medicine; Humans; Ivabradine; Natriuretic Agents; Natriuretic Peptide, Brain; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Risk Assessment; Risk Factors; Treatment Outcome	2012
Ivabradine: the hope for a good treatment of ischemic heart disease. Current medicinal chemistry, 2013, Volume: 20, Issue:14 Topics: Angina, Stable; Benzazepines; Coronary Artery Disease; Humans; Ivabradine; Myocardial Ischemia	2013
[Selective I(f) channel inhibition: an alternative for treating coronary artery disease?]. Herz, 2006, Volume: 31, Issue:1 Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Clonidine; Coronary Artery Disease; Humans; Isoindoles; Ivabradine; Phthalimides; Practice Guidelines as Topic; Practice Patterns, Physicians'	2006
Heart rate reduction via selective 'funny' channel blockers. Current opinion in pharmacology, 2007, Volume: 7, Issue:2 Topics: Angina Pectoris; Animals; Anti-Arrhythmia Agents; Benzazepines; Coronary Artery Disease; Drug Delivery Systems; Heart Rate; Humans; Ion Channel Gating; Ion Channels; Ivabradine; Sinoatrial Node	2007

Trials

26 trial(s) available for ivabradine and Arteriosclerosis, Coronary

Article	Year
Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease. Journal of hypertension, 2019, Volume: 37, Issue:5 Topics: Aged; Aorta; Arterial Pressure; Brachial Artery; Cardiovascular Agents; Chronic Disease; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Endothelium; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Pulse Wave Analysis; Vascular Stiffness; Vasodilation	2019
Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapy. Acta radiologica (Stockholm, Sweden : 1987), 2014, Volume: 55, Issue:6 Topics: Administration, Oral; Anti-Arrhythmia Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Injections, Intravenous; Ivabradine; Male; Metoprolol; Middle Aged; Premedication; Prospective Studies; Time	2014
Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabra American heart journal, 2013, Volume: 166, Issue:4 Topics: Aged; Benzazepines; Coronary Artery Disease; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Global Health; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Morbidity; Radiography; Retrospective Studies; Stroke Volume; Survival Rate; Treatment Outcome; Ventricular Function, Left	2013
The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease. Heart (British Cardiac Society), 2014, Volume: 100, Issue:2 Topics: Aged; Benzazepines; Blood Flow Velocity; Cardiac Catheterization; Collateral Circulation; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Electrocardiography; Female; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Middle Aged; Prospective Studies; Single-Blind Method; Treatment Outcome	2014
Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease. Cardiovascular ultrasound, 2014, Jan-31, Volume: 12 Topics: Anti-Arrhythmia Agents; Benzazepines; Coronary Artery Disease; Coronary Circulation; Echocardiography; Female; Heart Rate; Humans; Image Enhancement; Ivabradine; Male; Middle Aged; Pilot Projects; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome	2014
Ivabradine therapy to unmask heart rate-independent effects of β-blockers on pulse wave reflections. Clinical research in cardiology : official journal of the German Cardiac Society, 2014, Volume: 103, Issue:6 Topics: Adrenergic beta-Antagonists; Benzazepines; Coronary Artery Disease; Exercise Test; Heart Rate; Humans; Hypertension; Ivabradine; Male; Middle Aged; Pulse Wave Analysis; Renin-Angiotensin System	2014
Ivabradine in stable coronary artery disease without clinical heart failure. The New England journal of medicine, 2014, Sep-18, Volume: 371, Issue:12 Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Diseases; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intention to Treat Analysis; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Risk	2014
Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial infarc Trials, 2014, Sep-07, Volume: 15 Topics: Anti-Arrhythmia Agents; Atorvastatin; Benzazepines; Biomarkers; Clinical Protocols; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Emergencies; Femoral Neck Fractures; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Middle Aged; Myocardial Infarction; Orthopedic Procedures; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Pyrroles; Research Design; Risk Factors; Severity of Illness Index; Tachycardia, Ventricular; Tomography, X-Ray Computed; Treatment Outcome; Victoria	2014
Ivabradine and patients with coronary artery disease: more cardiovascular events. Prescrire international, 2014, Volume: 23, Issue:155 Topics: Benzazepines; Coronary Artery Disease; Double-Blind Method; Humans; Ivabradine	2014
Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate. Advances in therapy, 2015, Volume: 32, Issue:8 Topics: Aged; Benzazepines; Bisoprolol; Blood Flow Velocity; Cardiovascular Agents; Coronary Artery Disease; Double-Blind Method; Drug Monitoring; Echocardiography, Doppler; Female; Fractional Flow Reserve, Myocardial; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Treatment Outcome	2015
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study. European heart journal, 2015, Dec-07, Volume: 36, Issue:46 Topics: Aged; Atrial Fibrillation; Benzazepines; Bradycardia; Cardiovascular Agents; Coronary Artery Disease; Double-Blind Method; Female; Humans; Ivabradine; Male; Middle Aged; Risk Factors	2015
Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease. Hypertension (Dallas, Tex. : 1979), 2015, Volume: 66, Issue:6 Topics: Aged; Aorta; Benzazepines; Blood Pressure; Cardiovascular Agents; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Perfusion Imaging; Time Factors; Treatment Outcome	2015
Ivabradine reduces myocardial stunning in patients with exercise-inducible ischaemia. Basic research in cardiology, 2015, Volume: 110, Issue:6 Topics: Aged; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Exercise; Hemodynamics; Humans; Ivabradine; Male; Middle Aged; Myocardial Stunning	2015
β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index. Clinical research in cardiology : official journal of the German Cardiac Society, 2016, Volume: 105, Issue:6 Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Benzazepines; Biomarkers; Coronary Artery Disease; Drug Substitution; Dyspnea; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left	2016
Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy. Circulation. Cardiovascular quality and outcomes, 2016, Volume: 9, Issue:1 Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Female; Humans; Ivabradine; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Visual Analog Scale	2016
[Status of β-blocker use and heart rate control in Chinese patients with stable coronary artery disease]. Zhonghua xin xue guan bing za zhi, 2016, Volume: 44, Issue:1 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Infarction; Outpatients; Percutaneous Coronary Intervention; Prospective Studies; Registries; Risk Factors	2016
Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease. Hypertension (Dallas, Tex. : 1979), 2016, Volume: 67, Issue:6 Topics: Aged; Benzazepines; Blood Pressure; Blood Pressure Determination; Cardiovascular Agents; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Heart Rate; Humans; Ivabradine; Linear Models; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Single-Blind Method; Stroke Volume; Treatment Outcome	2016
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study. Clinical research in cardiology : official journal of the German Cardiac Society, 2017, Volume: 106, Issue:1 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Benzazepines; Brachial Artery; Cardiovascular Agents; Coronary Artery Disease; Endothelium, Vascular; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Recovery of Function; Rome; Time Factors; Treatment Outcome; Vasodilation	2017
The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population. Cardiology, 2008, Volume: 110, Issue:4 Topics: Aged; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Diabetes Complications; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Ivabradine; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left	2008
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. European heart journal, 2009, Volume: 30, Issue:19 Topics: Adult; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Coronary Artery Disease; Death, Sudden, Cardiac; Double-Blind Method; Female; Hospitalization; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left; Young Adult	2009
Arrhythmic effects of ivabradine in patients with coronary artery disease. Clinical and investigative medicine. Medecine clinique et experimentale, 2009, Oct-01, Volume: 32, Issue:5 Topics: Adult; Aged; Arrhythmias, Cardiac; Benzazepines; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged	2009
Incremental value and safety of oral ivabradine for heart rate reduction in computed tomography coronary angiography. International journal of cardiology, 2012, Apr-05, Volume: 156, Issue:1 Topics: Administration, Oral; Aged; Benzazepines; Bradycardia; Coronary Angiography; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Tomography, X-Ray Computed	2012
Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy). The American journal of cardiology, 2011, Mar-15, Volume: 107, Issue:6 Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Placebos; Systole; Treatment Outcome; Ventricular Dysfunction, Left	2011
Ivabradine versus metoprolol for heart rate reduction before coronary computed tomography angiography. The American journal of cardiology, 2012, Jan-15, Volume: 109, Issue:2 Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Benzazepines; Coronary Angiography; Coronary Artery Disease; Cyclic Nucleotide-Gated Cation Channels; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Rate; Humans; Ivabradine; Male; Metoprolol; Middle Aged; Myocardial Contraction; Premedication; Reproducibility of Results; Tomography, X-Ray Computed	2012
Safety and efficacy of oral ivabradine as a heart rate-reducing agent in patients undergoing CT coronary angiography. The British journal of radiology, 2012, Volume: 85, Issue:1016 Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzazepines; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Metoprolol; Middle Aged; Prospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2012
Heart rate control with oral ivabradine in computed tomography coronary angiography: a randomized comparison of 7.5 mg vs 5 mg regimen. International journal of cardiology, 2013, Sep-20, Volume: 168, Issue:1 Topics: Administration, Oral; Aged; Benzazepines; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Retrospective Studies; Tomography, X-Ray Computed	2013

Other Studies

21 other study(ies) available for ivabradine and Arteriosclerosis, Coronary

Article	Year
Protection of Ivabradine Combined with Trimetazidine on Myocardial Injury after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease Evaluated by Magnetic Resonance Image under Convolutional Neural Network. Contrast media & molecular imaging, 2021, Volume: 2021 Topics: Aged; Aged, 80 and over; Artificial Intelligence; Coronary Artery Disease; Female; Heart; Heart Injuries; Humans; Ivabradine; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Neural Networks, Computer; Percutaneous Coronary Intervention; Trimetazidine	2021
Does Ranolazine Reduce Pain Perception With Cerebral Effect? Clinical therapeutics, 2020, Volume: 42, Issue:2 Topics: Acetanilides; Coronary Artery Disease; Humans; Ivabradine; Nicorandil; Pain Perception; Randomized Controlled Trials as Topic; Ranolazine	2020
Response to Letter Regarding Article, "Effects of the Antianginal Drugs Ranolazine, Nicorandil and Ivabradine on Coronary Microvascular Function in Patients with Non-obstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials". Clinical therapeutics, 2020, Volume: 42, Issue:2 Topics: Coronary Artery Disease; Humans; Ivabradine; Nicorandil; Randomized Controlled Trials as Topic; Ranolazine	2020
Heart rate-reducing therapy with add-on ivabradine and bisoprolol before coronary computed tomographic angiography in a fast-track ambulatory setting. The Journal of international medical research, 2018, Volume: 46, Issue:6 Topics: Aged; Bisoprolol; Cardiovascular Agents; Clinical Protocols; Computed Tomography Angiography; Coronary Artery Disease; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Retrospective Studies	2018
Ivabradine for coronary artery disease and/or heart failure-a protocol for a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis. Systematic reviews, 2019, 02-01, Volume: 8, Issue:1 Topics: Coronary Artery Disease; Heart Failure; Humans; Ivabradine; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Research Design; Systematic Reviews as Topic	2019
The role of ivabradine in the incidence of perioperative coronary complications in patients undergoing vascular surgery. International journal of cardiology, 2013, Oct-09, Volume: 168, Issue:4 Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Coronary Artery Disease; Female; Humans; Incidence; Ivabradine; Male; Postoperative Complications; Vascular Surgical Procedures	2013
Pre-treatment with a sinus node blockade, ivabradine, before coronary CT angiography: a retrospective audit. Clinical radiology, 2013, Volume: 68, Issue:10 Topics: Administration, Oral; Adrenergic beta-Antagonists; Analysis of Variance; Benzazepines; Chi-Square Distribution; Contrast Media; Coronary Angiography; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Triiodobenzoic Acids	2013
The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease, another funny aspect of the funny channel? Heart (British Cardiac Society), 2014, Volume: 100, Issue:2 Topics: Animals; Benzazepines; Collateral Circulation; Coronary Artery Disease; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Mice; Neovascularization, Physiologic	2014
Exercise and the heart. Heart (British Cardiac Society), 2014, Volume: 100, Issue:13 Topics: Anti-Arrhythmia Agents; Benzazepines; Biomedical Research; Cardiology; Coronary Artery Disease; Cost-Benefit Analysis; Drug Costs; Drug-Eluting Stents; Echocardiography, Doppler; Exercise; Heart Failure; Humans; Ivabradine; Life Style; Percutaneous Coronary Intervention; Predictive Value of Tests; Prognosis; Prosthesis Design; Risk Factors; Treatment Outcome	2014
The challenges with chronic angina. The New England journal of medicine, 2014, Sep-18, Volume: 371, Issue:12 Topics: Benzazepines; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male	2014
[The SIGNIFY study]. Giornale italiano di cardiologia (2006), 2014, Volume: 15, Issue:11 Topics: Benzazepines; Coronary Artery Disease; Double-Blind Method; Follow-Up Studies; Humans; Ivabradine; Randomized Controlled Trials as Topic; Treatment Outcome	2014
Can ivabradine still be used in clinical practice after the 'SIGNIFY' trial? European heart journal, 2015, Jun-07, Volume: 36, Issue:22 Topics: Anti-Arrhythmia Agents; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Coronary Artery Disease; Humans; Ivabradine; Treatment Outcome	2015
Ivabradine: more precautions to protect patients with coronary artery disease because of its cardiac harms. Prescrire international, 2015, Volume: 24, Issue:165 Topics: Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Humans; Ivabradine	2015
Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization. Angiology, 2017, Volume: 68, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina, Stable; Cardiovascular Agents; Coronary Artery Disease; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Percutaneous Coronary Intervention; Quality of Life	2017
Atrial Fibrillation After Coronary Artery Bypass Surgery: Can Ivabradine Reduce Its Occurrence? Journal of cardiovascular electrophysiology, 2016, Volume: 27, Issue:6 Topics: Action Potentials; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzazepines; Bisoprolol; Coronary Artery Bypass; Coronary Artery Disease; Drug Administration Schedule; Drug Therapy, Combination; Egypt; Elective Surgical Procedures; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Pilot Projects; Prospective Studies; Time Factors; Treatment Outcome	2016
Ivabradine in Coronary Heart Disease-The Emperor Has No Clothes. The American journal of cardiology, 2017, 08-01, Volume: 120, Issue:3 Topics: Arterial Pressure; Cardiac Catheterization; Cardiovascular Agents; Coronary Artery Disease; Heart Rate; Humans; Ivabradine; Myocardium; Oxygen Consumption; Single-Blind Method; Stroke Volume; Treatment Outcome	2017
Interpreting clinical trials: the 'beautiful' case. Fundamental & clinical pharmacology, 2009, Volume: 23, Issue:2 Topics: Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Endpoint Determination; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left	2009
A BEAUTIFUL lesson--ivabradine protects from ischaemia, but not from heart failure: through heart rate reduction or more? European heart journal, 2009, Volume: 30, Issue:19 Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Coronary Artery Disease; Heart Failure; Humans; Ivabradine; Myocardial Ischemia; Retrospective Studies; Ventricular Dysfunction, Left	2009
Ivabradine improves coronary flow reserve in patients with stable coronary artery disease. Atherosclerosis, 2011, Volume: 215, Issue:1 Topics: Aged; Benzazepines; Blood Flow Velocity; Coronary Artery Disease; Coronary Circulation; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged	2011
[Update coronary artery disease: important progresses in acute and chronic therapy]. MMW Fortschritte der Medizin, 2012, Mar-22, Volume: 154, Issue:5 Topics: Acetanilides; Angina Pectoris; Angioplasty, Balloon, Coronary; Benzazepines; Coronary Artery Disease; Early Medical Intervention; Humans; Ivabradine; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ranolazine; Survival Rate; Thrombolytic Therapy	2012
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in pa American heart journal, 2006, Volume: 152, Issue:5 Topics: Adult; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Double-Blind Method; Female; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Ventricular Dysfunction, Left	2006